Inserm Transfert Initiative logo

Inserm Transfert Initiative

Europe, Ile-de-France, France, Paris

Description

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech

Investor Profile

Inserm Transfert Initiative has made 19 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (37%)
  • Series Unknown (26%)
  • Series B (21%)
  • Seed (16%)

Country Focus

  • France (74%)
  • Switzerland (26%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Medical Device
  • 3d Printing
  • Biopharma
  • Pharmaceutical
  • Genetics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inserm Transfert Initiative frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
I
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
CH
North America, New York, United States, New York
Co-Investments: 3
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 3
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 8
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by Inserm Transfert Initiative?

VectivBio

Basel, Basel-Stadt, Switzerland

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

BiotechnologyHealth CareMedical
Series UnknownOct 19, 2020
Amount Raised: $110,000,000
Eyevensys

Paris, Ile-de-France, France

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

BiotechnologyMedical DeviceTherapeutics
Series BJan 8, 2020
Amount Raised: $30,000,000
VectivBio

Basel, Basel-Stadt, Switzerland

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

BiotechnologyHealth CareMedical
Series AJan 8, 2020
Amount Raised: $35,000,000
Aelis Farma

Bordeaux, Aquitaine, France

Aelis Farma is a biotech company conducting research and development on innovative signaling specific drugs

BiotechnologyTherapeutics
Series UnknownDec 13, 2019
Amount Raised: $12,232,552
Therachon

Basel, Basel-Stadt, Switzerland

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases

BiotechnologyMedicalTherapeutics
Series BAug 9, 2018
Amount Raised: $60,000,000
BIOMODEX

Paris, Ile-de-France, France

BIOMODEX is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.

3D PrintingHealth CareMedical Device
Series AJun 8, 2018
Amount Raised: $15,000,000
ENYO Pharma

Lyon, Rhone-Alpes, France

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

BiopharmaBiotechnologyMedical
Series BJun 4, 2018
Amount Raised: $46,800,485
Step Pharma

Paris, Ile-de-France, France

Step Pharma is a biotechnology company.

BiotechnologyPharmaceutical
Series ANov 21, 2017
Amount Raised: $17,025,614
Therachon

Basel, Basel-Stadt, Switzerland

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases

BiotechnologyMedicalTherapeutics
Series AJan 6, 2017
Amount Raised: $5,000,000
BIOMODEX

Paris, Ile-de-France, France

BIOMODEX is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.

3D PrintingHealth CareMedical Device
SeedApr 11, 2016
Amount Raised: $3,600,000